Position in GSK
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$1,845,553
+$110,028 QoQ
Shares Held
33,440
-5.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Anchor Investment Management, LLC holds $69,112,010 across 15 Drug Manufacturers - General names. GSK ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
87,612 | $21,415,877 | |
| 2 | ABBV |
AbbVie Inc.
|
87,821 | $19,100,189 | |
| 3 | LLY |
ELI LILLY & Co
|
13,180 | $12,122,568 | |
| 4 | MRK |
Merck & Co., Inc.
|
65,472 | $7,875,626 | |
| 5 | PFE |
Pfizer Inc
|
87,568 | $2,458,909 | |
| 6 | GSK |
GSK plc
This page
|
33,440 | $1,845,553 | |
| 7 | AMGN |
Amgen Inc
|
4,884 | $1,718,435 | |
| 8 | NVS |
Novartis AG
|
6,726 | $1,027,396 |
All Filings in GSK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,845,553 | 33,440 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,735,525 | 35,390 | Shares | Sole | 2026-02-26 | |
| 2025-09-30 | $1,549,444 | 35,900 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,413,120 | 36,800 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $1,584,775 | 40,908 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $1,402,109 | 41,458 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,844,423 | 45,118 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $1,872,524 | 48,637 | Shares | Sole | 2024-09-20 | |
| 2024-03-31 | $2,125,794 | 49,587 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,853,518 | 50,014 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $1,744,096 | 48,113 | Shares | Sole | 2024-01-02 | |
| 2023-06-30 | $1,664,851 | 46,713 | Shares | Sole | 2024-01-02 | |
| 2023-03-31 | $1,195,950 | 33,613 | Shares | Sole | 2024-01-02 | |
| 2022-12-31 | $33,734 | 960 | Shares | Sole | 2024-01-02 | |
| 2022-09-30 | $28,252 | 960 | Shares | Sole | 2024-01-02 | |
| 2022-06-30 | $51,233 | 1,200 | Shares | Sole | 2024-01-02 | |
| 2022-03-31 | $51,268 | 1,200 | Shares | Sole | 2024-01-02 | |
| 2021-12-31 | $51,903 | 1,200 | Shares | Sole | 2024-01-02 | |
| 2021-09-30 | $55,465 | 1,480 | Shares | Sole | 2024-01-02 | |
| 2021-06-30 | $49,951 | 1,279 | Shares | Sole | 2024-01-02 | |
| 2021-03-31 | $76,205 | 2,177 | Shares | Sole | 2024-01-02 | |
| 2020-12-31 | $189,671 | 5,255 | Shares | Sole | 2024-01-02 | |
| 2020-09-30 | $223,497 | 6,054 | Shares | Sole | 2024-01-02 | |
| 2020-06-30 | $227,118 | 5,677 | Shares | Sole | 2024-01-02 | |
| 2020-03-31 | $210,934 | 5,676 | Shares | Sole | 2024-01-02 | |
| No filing history on record for this holder in this stock. | ||||||